Hybridoma Technology
Hybridoma Technology
MONOCLONAL
Monoclonal antibodies are antibodies that are identical because they are
produced by one type of immune cell, all clones of a single parent cell.
HYBRIDOMA TECHNOLOGY
• Hybridoma technology is a method in biotechnology that
is used to produce large quantities of monoclonal
antibodies
• The cells are produced by the fusion of B-cell(B-
lymphocytes)
with myeloma cells to produce hybrid cell which is called
hybridoma (produces a single type of antibody)
B-cell + myeloma cell
hybrid cells(HYBRIDOMA)
• Hybridoma technology was discovered in1975 by
Georges Kohler and Cesar Milstein
PRINCIPLE
STEPS:
a)Immunization
In hydridoma technology the very first step is to immunize an
animal(eg: mouse) with appropriate antigen. Isolate B-cell from spleen
of animal.
c)Cell fusion
In this step B-cells are fused with myeloma cells and form hybrid
cells.The cells are exposed to PEG(polyethylene glycol)for a short
period and then removed by washing.
d)Selection of Hybridoma
When the cells are cultured in HAT (hypoxanthine aminopterin
thymidine) only the hybridoma cells grow, while the rest will
slowly disappear.
Selection of a single antibody producing hybrid cell is very
important which is possible if the hybridomas are isolated and
are grown individually.
cells
frozen
MONOCLONAL
ANTIBODIES ARE
PURIFIED